TY - JOUR T1 - COVID-19 mRNA vaccine is not detected in human milk JF - medRxiv DO - 10.1101/2021.03.05.21252998 SP - 2021.03.05.21252998 AU - Yarden Golan AU - Mary Prahl AU - Arianna Cassidy AU - Christine Y. Lin AU - Nadav Ahituv AU - Valerie J. Flaherman AU - Stephanie L. Gaw Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/03/08/2021.03.05.21252998.abstract N2 - Several countries have recently approved the use of mRNA vaccines against COVID-19 under an emergency use authorization. However, no pregnant or lactating individuals were included in the Phase 3 clinical trials of these vaccines despite belonging to a group at high risk for severe complications of COVID-19 infection. We show here that the mRNA from anti-COVID BNT162b2 (Pfizer) and mRNA-1273 (Moderna) vaccines is not detected in human breast milk samples collected 4-48 hours post-vaccine. These results strengthen the recommendation of ABM and WHO that lactating individuals who receive the anti-COVID-19 mRNA-based vaccine should continue to breastfeed their infants uninterrupted.Competing Interest StatementThe authors have declared no competing interest.Funding StatementYarden Golan is an Awardee of the Weizmann Institute of Science -National Postdoctoral Award Program for Advancing Women in Science, of the International Society for Research In Human Milk and Lactation (ISRHML) Trainee Bridge Fund, and of the Human Frontier Science Program.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The University of California San Francisco (UCSF) institutional review board approved the study (20-32077).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data from this manuscript will be available. ER -